It decreases proinflammatory cytokines, thereby attenuating inflammatory bowel disease by targeting and downregulating the pyroptotic protein, NLR family pyrin domain containing 3 (NLRP3) [267]. Here, NLRP3 is linked to inflammatory bowel disease.